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Background—Millennium Development Goal (MDG) 5 calls for a reduction of 75% in the 
maternal mortality ratio (MMR) between 1990 and 2015. We estimated levels and trends in 
maternal mortality for 183 countries to assess progress made. Based on MMR estimates for 2015, 
we constructed scenario-based projections to highlight the accelerations needed to accomplish the 
Sustainable Development Goal (SDG) global target of less than 70 maternal deaths per 100,000 
live births globally by 2030.
Methods—We updated the open access UN Maternal Mortality Estimation Inter-agency Group 
(MMEIG) database. Based upon nationally-representative data for 171 countries, we generated 
estimates of maternal mortality and related indicators with uncertainty intervals using a Bayesian 
model, which extends and refines the previous UN MMEIG estimation approach. The model 
combines the rate of change implied by a multilevel regression model with a time series model to 
capture data-driven changes in country-specific MMRs, and includes a data model to adjust for 
systematic and random errors associated with different data sources.
Results—The global MMR declined from 385 deaths per 100,000 live births (80% uncertainty 
interval ranges from 359 to 427) in 1990 to 216 (207 to 249) in 2015, corresponding to a relative 
decline of 43.9% (34.0 to 48.7) during the 25-year period, with 303,000 (291,000 to 349,000) 
maternal deaths globally in 2015. Regional progress in reducing the MMR since 1990 ranged from 
an annual rate of reduction of 1.8% (0 to 3.1) in the Caribbean to 5.0% (4.0 to 6.0) for Eastern 
Asia. Regional MMRs for 2015 range from 12 (11 to 14) for developed regions to 546 (511 to 
652) for sub-Saharan Africa. Accelerated progress will be needed to achieve the SDG goal; 
countries will need to reduce their MMRs at an annual rate of reduction of at least 7.5%.
Interpretation—Despite global progress in reducing maternal mortality, immediate action is 
required to begin making progress towards the ambitious SDG 2030 target, and ultimately 
eliminating preventable maternal mortality. While the rates of reduction that are required to 
achieve country-specific SDG targets are ambitious for the great majority of high mortality 
countries, the experience and rates of change between 2000 and 2010 in selected countries–those 
with concerted efforts to reduce the MMR- provide inspiration as well as guidance on how to 
accomplish the acceleration necessary to substantially reduce preventable maternal deaths.
Funding—Funding from grant R-155-000-146-112 from the National University of Singapore 
supported the research by LA and SZ. AG is the recipient of a National Institute of Child Health 
and Human Development, grant # T32-HD007275. Funding also provided by USAID and HRP 
(the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development 
and Research Training in Human Reproduction).
Introduction
At the landmark Millennium Summit in September 2000, world leaders agreed to improve 
the lives of the world’s poor through the acceptance of The Millennium Development Goals 
(MDGs). (1) The goals committed countries and international agencies to monitor progress 
on development and health outcomes between 1990 and 2015, including progress on 
reducing the maternal mortality ratio (MMR; number of maternal deaths per 100,000 live 
births) as MDG 5, which calls for a reduction of 75% in the MMR between 1990 and 2015.
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The process of monitoring progress towards the MDG 5 target exposed the difficulties of 
measuring MMR, for which there is a paucity of high quality data in many countries. 
Although maternal mortality had clearly been recognized as a concern and discussed at fora 
such as the 1987 Safe Motherhood Conference (Nairobi, Kenya), I994 International 
Conference on Population and Development (Cairo, Egypt), 1995 Fourth World Congress on 
Women (Beijing, China), and the 1997 Safe Motherhood Technical Consultation (Colombo, 
Sri Lanka), the MDG announcement provided significant technical and political impetus to 
improve maternal health.
To assist in the monitoring of progress towards MDG 5, the United Nations Maternal 
Mortality Estimation Inter-Agency Group, consisting of WHO, UNICEF, UNFPA, The 
World Bank and the United Nations Population Division, has produced estimates for 
maternal mortality on a regular basis, focusing on country-specific estimates from 1990 to 
the year of assessment. (2–8) The year 2015 marks the end of the MDG era and is the right 
time to reflect on the progress made. For this final MDG 5 reporting year, the UN MMEIG 
carried out a comprehensive assessment of MMR levels and trends for 183 countries, using a 
new Bayesian model (16) that extends upon prior UN MMEIG estimation methods. (8–11) 
The resulting estimates presented in this paper provide the first comprehensive overview of 
the progress that has been made in reducing the MMR from 1990 to 2015 at the global, 
regional and country level. The year 2015 also marks the start of the Sustainable 
Development Goals (SDGs), which include the target of reducing global maternal mortality 
to less than 70 deaths per 100,000 live births by 2030, with no country exceeding twice the 
global MMR of 140 maternal deaths per 100,000 live births. (9, 10)To highlight the potential 
impact of meeting this SDG target, we constructed scenario-based projections from 2016 to 
2030 based on the SDG target and compared them to a projection based on observed past 
rates of change.
Methods
This section describes the data inputs, adjustments, assumptions, and statistical model 
developed by the UN MMEIG to measure levels and trends in maternal mortality for women 
aged 15–49. Definitions and concepts which are relevant for the measurement of maternal 
mortality are given in Table 1.
Data on maternal mortality
The UN MMEIG maintains a publicly available data set with nationally-representative data 
relevant to maternal mortality including data from vital statistics from civil registration 
systems (VR), special inquiries, surveillance sites, population-based household surveys 
(including Demographic Health Surveys, Multiple Indicator Cluster Surveys and 
Reproductive and Health Surveys) and censuses. The data compilation and search strategy 
are described in the web appendix (p 1). A summary of how information relating to maternal 
mortality is collected and categorized by the MMEIG is given in
Table 2, and Table 3 summarizes, by source type, what information related to maternal 
mortality was used for constructing MMR estimates. Generally, the desired data input was 
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the proportion of maternal deaths among deaths to women aged 15–49 (PM), and a reported 
MMR was used only if a PM was not available.
The full data base (and all model specifications) used in this analysis is available at http://
www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en/. The 
2015 update to the UN MMEIG database included over 200 additional records (referring to 
VR reporting years, studies or reports), resulting in a database with 2608 records that refer to 
3634 country-years of information in total, from 1985 until 2015 (see table 4). Source details 
for all non-VR data points are listed in the web appendix file (webappendix table 2, pp 5–
81).
Most data sources on maternal mortality have substantial uncertainty or known biases. The 
estimation approach attempts to account for these random and systematic errors, which are 
summarized in Table 3. For VR data, the observed proportion of maternal deaths among all 
deaths to women aged 15–49 was included as the data input. For VR country-years based on 
ICD-9, deaths coded to 630–676 were used and for those based upon ICD-10, data coded to 
codes O00-O95, O98-O99 and A34 were used (which include only those maternal deaths for 
which the timing corresponds to the definition of a maternal death). An important systematic 
bias associated with VR data is the potential misclassification of maternal deaths, resulting 
from error in medical reporting and certification of the cause of death or error in applying 
the correct ICD code. Misclassification in VR tends to result in undercounting of maternal 
deaths because there is higher likelihood of misclassifying a maternal death as a non-
maternal death rather than in the opposite direction. Earlier analyses found that a large 
number of nationally representative inquiries into maternal death reporting conducted by 
countries with VR data consistently suggest that VR systems fail to record around 50% of 
maternal deaths. (6–8)
Some studies are only able to record information on pregnancy-related deaths (which refer 
to deaths to women while pregnant or within 42 days of termination of pregnancy, 
irrespective of the cause of death, see table 2). These observations are subject to systematic 
error as pregnancy-related deaths tend to exceed maternal deaths because of the inclusion of 
deaths that are not causally related to the pregnancy. However, because pregnancy-related 
deaths are (1) reported by a family member and (2) pertain to deaths occurring during 
pregnancy rather than deaths for which the cause has been medically classified, surveys such 
as the Demographic Health Survey, and other sources that report pregnancy-related deaths 
may also be subject to underreporting, especially for deaths occurring early in pregnancy 
(and thus unbeknownst to the reporting family member). (11)
Sources and construction of other model inputs
Several other inputs are used to estimate MMR and related outcomes. This includes life 
table entries from WHO life tables, which provides estimates of all-cause deaths among 
women of reproductive age (12), estimates of live births from the United Nations Population 
Division World Population Prospects 2015 (13), and estimates of deaths due to HIV/AIDS 
among females 15–49 years from UNAIDS (14) (details on how these inputs were used are 
provided in the statistical analysis section). Three covariates were used in the statistical 
analysis: the gross domestic product per capita (GDP), the general fertility rate (GFR), and 
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the proportion of births delivered by a skilled health personnel (SAB). The rationale for the 
choice of these covariates has been described by Wilmoth et al (15), the sources and details 
on constructing trends for these covariates are also provided in the web appendix (section 3).
Statistical analysis
Maternal mortality indicators were estimated with a new Bayesian maternal mortality 
estimation model, referred to as the BMat model. (16) This model refines the approach 
previously used by the MMEIG to better incorporate trends in, and uncertainty around, 
country data. In summary, BMat is able to track high quality data very closely, handle 
countries that move from survey-based data sources in earlier time periods to newly scaled 
up VR in later time periods, and combine information from data and covariates for countries 
with limited data while producing covariate-driven estimates for countries without data. The 
flexibility of the BMat model eliminates the need for grouping countries based on data 
availability: one model is used for all countries, regardless of data sources available. Below 
we provide a technical summary of both the model set-up for MMR as well as the data 
model used to account for systematic and random errors in the data points; a technical 
description of the full model and software are available elsewhere. (16)
In the BMat model, the MMR for each country-year is modeled as the sum of the AIDS 
MMR and the non-AIDS MMR, where non-AIDS MMR refers to maternal deaths due to 
direct obstetric causes or to indirect causes other than HIV while AIDS maternal deaths are 
those AIDS deaths for which pregnancy was a substantial aggravating factor. Given the 
substantial impact of the HIV/AIDS epidemic on mortality in countries with generalized 
epidemics, the AIDS MMR was modeled separately to be able to capture the trends in 
maternal mortality associated with the epidemic, following the same procedure used for 
previous UN MMEIG publications (6–8).
The model for the non-AIDS MMR consists of two components. The main component is a 
Bayesian hierarchical regression model. This regression model assumes that the logged 
proportion of non-AIDS maternal deaths among all non-AIDS deaths to women of 
reproductive age (the dependent variable) is a linear function of random country-specific 
intercepts and three predictor variables: GDP, GFR and SAB. This multilevel regression 
model was used in previous estimation rounds to obtain non-AIDS MMR estimates for 
countries without sufficient high quality data from vital registration systems. (6–8) In the 
BMat model, this regression model was extended to capture country-specific trends in the 
non-AIDS MMR as suggested by the data: the regression-based and hence covariate-driven 
estimates for rates of reduction in the non-AIDS MMR are combined with country-year-
specific distortion terms. These distortion terms were modelled with a time series model and 
estimated for all country-years. The effect was as follows: if data in a country suggested that 
the non-AIDS MMR decreased faster in year t than expected based on covariates, the data-
driven distortion term for that year was estimated to be greater than 0 to capture the 
acceleration in the MMR reduction beyond the reduction captured by covariates. Similarly, 
if the MMR reduced less than expected based on covariates, the distortion was estimated to 
be negative to capture the deceleration in the MMR reduction as compared to the expected 
covariate-based reduction. For countries with ample data across time, the distortion term 
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plays a more dominant role in the estimation, allowing for the model to track patterns in 
country data, whereas for countries with limited data, the estimates are more strongly 
supported by the expected trend implied by the covariates. For countries with continuous 
time series of high-quality VR data, the model follows the data very closely (given 
adjustments for misclassification).
We used data quality models to account for systematic and random errors associated with the 
observed PMs: we assumed that each observed logged PM is equal to the sum of the true 
logged PM, adjusted for reporting issues to make it comparable to the observed value, and 
additional error which was assumed to be normally distributed. Details are provided in the 
technical documentation. (15, 16) In summary, adjustments for reporting issues (outlined in 
table 3) were similar to adjustments used in previous UN MMEIG studies (6–8). As 
compared to past MMEIG publications, late maternal deaths were excluded from ICD-10 
based PMs, and adjustments were updated accordingly to reflect this change in data inputs. 
Uncertainty in the adjustment parameters was accounted for through prior distributions on 
the adjustment parameters and/or added to the overall error variance of the observation. For 
each observation, total error variance was set equal to its stochastic or sampling error 
variance, combined with a non-sampling or additional random error variance term for 
observations from surveys and miscellaneous sources. The resulting total error variances 
were taken into account in the model fitting such that, with systematic errors being equal, 
observations of the PM with smaller error variances carried a greater weight in determining 
the estimates as compared to observations with larger error variances.
Maternal mortality indicators
In addition to the MMR estimates, we also calculated the annual (continuous) rate of 
reduction (ARR), the life time risk of maternal mortality (LTR) (17) and the maternal 
mortality rate (MMRate). See table 1 for definitions.
Uncertainty assessment and reporting
The BMat model is a Bayesian model. We used a Markov Chain Monte Carlo (MCMC) 
algorithm to generate samples of the posterior distributions of all model parameters. (18) 
The MCMC sampling algorithm was implemented using JAGS 3·3·0 Open Source software 
(19) and the analysis was carried out in R. (20) Software programs and data are available 
[http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/
en].
The sampling algorithm produced a set of trajectories of the MMR for each country, from 
which other indicators and aggregate outcomes were derived. Point estimates for maternal 
mortality indicators are based on posterior medians or equivalently, 50th percentiles of 
posterior distributions. To obtain point estimates of relative reductions, ARRs, as well as 
aggregate outcomes (e.g., the global MMR) unrounded point estimates of the MMR were 
used. We computed 80% uncertainty intervals (UIs) for the MMR and all related outcomes 
using the 10th and 90th percentiles of the posterior distributions. The interpretation of such 
intervals is that there is a 10% chance that the true outcome is below the interval, and there 
is a 10% chance that the true outcome is above the interval. We chose to report 80% UIs as 
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opposed to the more standard 95% intervals because of the substantial uncertainty inherent 
in maternal mortality outcomes: intervals based on higher uncertainty levels quickly lose 
their utility to present meaningful summaries of a range of likely outcomes.
The UIs for the MMR and related maternal mortality outcomes assess the uncertainty in the 
indicators based on the available data and uncertain model parameters, such as data 
adjustment parameters. The uncertainty assessment does not include the uncertainty in any 
of the demographic indicators that were used as inputs to our model, including the total 
number of deaths to women of reproductive ages and the number of births.
Country consultation
A Country Consultation process for maternal mortality estimates represents official 
communication between WHO and Member States, providing the opportunity for countries 
to share data or provide additional information about national data sources. The process does 
not involve obtaining approval from Member States regarding the estimates. The MMEIG 
estimates are intended to describe internationally comparable estimates of maternal 
mortality, hence they may differ from nationally quoted figures developed using other 
methodology. During the country consultation for the 2015 estimation round, the MMEIG 
received new data from twenty six countries that were deemed to be of sufficient quality for 
inclusion.
Scenario-based projection for 2030
We constructed a scenario-based projection for 2030 to highlight the potential impact of 
meeting the targets proposed in the post-2015, Sustainable Development Goal (SDG) 
Framework.(10). The SDG target is to reduce the global MMR to 70 deaths per 100,000 live 
births in 2030, and in addition, to reduce the MMR in all countries to be lower than twice the 
global MMR, thus 140, in 2030. (9) As a comparison, we also generated country-specific 
MMR projections from 2016 to 2030 based on the median of the country-specific ARRs that 
were estimated for the period 2000–2010, to represent what would happen if the “typical 
country” experience continued until 2030. The ARR for 2000–2010 was chosen to reflect 
the recent ARR, as opposed to a later period, to exclude more recent years for which MMR 
estimates are model-driven for the majority of countries. The median ARR was calculated 
based on all countries, regardless of the respective level of MMR in the year 2000, because 
SDG target rates will apply to all countries regardless of their starting level in 2015.
Role of funding
No funding bodies had any role in the study design, data collection and analysis; in the 
writing of the manuscript; and in the decision to submit the paper for publication. LA, DC, 
SZ, ABM, and DH had full access to all the data in the study and all authors had final 
responsibility for the decision to submit for publication.
Results
The global maternal mortality ratio decreased from 385 deaths per 100,000 live births (80% 
UI range from 359 to 427) in 1990 to 216 (207 to 249) in 2015, corresponding to a 43.9% 
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(34.0 to 48.7) decline and an ARR of 2.3 % (1.7 to 2.7) for the period (figure 1 and 
webappendix table 3 ). Substantial differences between regions exist in terms of progress 
made as well as current levels of maternal mortality. The highest regional rate of decline for 
the period 1990–2015 was observed in Eastern Asia (ARR given by 5.0 % (4.0 to 6.0 )) and 
the lowest was in the Caribbean (ARR 1.8 (0.0 to 3.1)). Regional MMRs for 2015 range 
from 12 (11 to 14) for developed regions to 546 (511 to 652) for sub-Saharan Africa.
The annual number of global deaths decreased from 532,000 (496,000 to 590,000) in 1990 
to 303,000 (291,000 to 349,000) ) in 2015. The largest share of global maternal deaths in 
2015 occurred in Sub-Saharan Africa (66.3%) corresponding to a total of 201,000 (188,000 
to 240,000)) maternal deaths for that region. Estimates for all years can be downloaded from 
http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2015/en/ 
Cumulatively from 1990 to 2015, 10.7 million women died globally due to maternal causes.
Regional findings may mask variation across countries within a region and regional MMRs 
may be driven by the MMRs of countries with larger numbers of live births. Country-
specific MMR estimates are presented in webappendix table 3 for selected years, estimates 
for all years are included in figure 2 in the webappendix. Figure 2 illustrates the MMR level 
for 2015, with point estimates given in graph A, lower bounds of 80% UIs in B and upper 
bounds in C, where a lower (upper) bound refers to that MMR value for which there is a 
10% chance that the country’s MMR is below (above) it. Globally in 2015, the median of 
the country-specific MMR point estimates was 54 and country levels range from 3 (2 to 3) 
deaths per 100,000 live births in Finland to 1360 (999 to 1980) in Sierra Leone. The lower 
bound of the 80% UIs exceeds 500 for eight countries (Central African Republic, Chad, 
Democratic Republic of the Congo, Guinea, Liberia, Nigeria, Sierra Leone, South Sudan), 
hence the chance that the MMR is below 500 is less than 10% for these countries. The point 
estimate for the MMR in 2015 exceeds 500 for an additional 12 countries (Burundi, 
Cameroon, Cote d’Ivoire, Eritrea, Gambia, Guinea-Bissau, Kenya, Malawi, Mali, 
Mauritania, Niger and Somalia). Based on point estimates, there are 10 countries with an 
MMR of 5 or less (Austria, Belarus, Czech Republic, Finland, Greece, Iceland, Italy, 
Kuwait, Norway, Poland, Spain, and Sweden). Based on the upper bounds of 80% UIs, there 
is at least a 90% chance that the MMR is less than 5 for Finland, Greece and Poland.
Figure 3 shows the relative reduction between 1990 and 2015 for the 95 countries with a 
high maternal mortality (point estimate of MMR greater than 100) in 1990. The countries 
are grouped into four categories as explained in table 5 based on the point estimate for the 
relative reduction between 1990 and 2015, to assess whether MDG 5 was achieved, as well 
as the lower bound of their respective 80% UI. For the countries in figure 3, the greatest 
progress in terms of a relative reduction in MMR has been made in the nine countries in 
category 1 (Bhutan, Cabo Verde, Cambodia, Iran, Lao, Maldives, Mongolia, Rwanda, 
Timor-Leste), for which the point estimate of the reduction between 1990 and 2015 suggests 
that MDG 5 target of a 75% reduction has been met. Of the category 1 countries, the 
probability of having reached MDG5 is greater than 90% for Cambodia and the Maldives 
but smaller than 90% for all other countries, suggesting that the finding is less certain for 
those countries. The other categories are based on point estimates as well as the lower 
bounds of the 80% UIs for the relative decline. The motivation for taking into account 
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uncertainty intervals when grouping countries is to avoid drawing conclusions based solely 
on point estimates, which may be highly uncertain. For example, in Nigeria, the point 
estimate for the relative reduction in MMR since 1990 suggests a decrease of 39.6%. 
However, the lower bound of the 80% uncertainty interval is given by -5.0%, which is below 
0, hence the chance that no progress has been made is greater than 10%; the available 
information on maternal mortality in Nigeria is too uncertain to absolutely state that progress 
has been made, illustrating the need to include uncertainty assessments in a categorization of 
country progress. The largest proportion of countries (21.3%, 39 countries) are in category 
2; for countries in this category, the best estimate suggests at least a 50% reduction in MMR, 
and there is at least a 90% change that the MMR decreased by 25% since 1990. For the 21 
countries in category 3, the best estimate suggests that the MMR reduced by at least 25% 
and there is at least a 90% change that the MMR has declined, but this does not hold true for 
the 26 countries in category 4. For category 4 countries, the chance that the MMR decreased 
is less than 90% or the point estimate of the country-specific decline is less than 25%.
Global and regional estimates for the life time risk of a maternal deaths are displayed in 
Figure 4. Globally, the risk more than halved between 1990 and 2015, from 14 (13 to 15) 
maternal deaths per 1,000 women over their lifetimes to 6 (5 to 6) deaths, or equivalently, 
from 1 death per 73 women (66 to 78) in 1990 to 1 per 180 women (160 to 190) in 2015. 
The largest relative declines occurred in Eastern Asia and Southern Asia (declines of 84% 
and 81% respectively). The largest absolute decline occurred in sub-Saharan Africa, where 
the risk decreased from one per 16 women (14 to 18) in 1990 to one per 36 (30 to 39) in 
2015. At the country level, life time risks in 2015 range from 1 per 23,700 (18,000 to 
32,700) for Greece to 17 (12 to 23) for Sierra Leone. Similarly, the global maternal mortality 
rate decreased from 0.41 (0.38 to 0.45) per 1,000 women in 1990 to 0.17 (0.16 to 0.19) in 
2015 and at country level in 2015, the rate ranges from 0.001 (0.001 to 0.002) in Greece to 
2.0 (1.4 to 2.9) per 1,000 women in Sierra Leone (web appendix material table 4).
If the world would succeed in reducing the global MMR to less than 70 deaths per 100,000 
live births by 2030 (the SDG target), there would be 89,000 maternal deaths in 2030, and 
about 2.5 million deaths cumulatively between 2016 and 2030 (table 6). This projection of 
maternal mortality is substantially lower than the projection of a global MMR of 161 deaths 
per 100,000 live births in 2030 based country-specific ARRs of 2.9%, which is the median 
of the country-specific ARRs for the period 2000–2010 and represents the projection for a 
typical country. Regional projected MMRs range from 4 to 128 maternal deaths per 100,000 
live births under the SDG scenario, compared to outcomes between 8 and 357 under the 
more conservative projection.
At the country-level, the SDG-required ARR for 2016–2030 is 7.5% for all countries with an 
MMR below 432 deaths per 100,000 live births in 2015, which is beyond the ARR of 5.5% 
that was required for MDG 5. Ten countries (Belarus, Cambodia, Estonia, Kazakhstan, 
Lebanon, Mongolia, Poland, Rwanda, Timor-Leste, Turkey) had point estimates of the 
ARRs in 2000–2010 that exceeded this SDG-required ARR. For 30 countries with MMRs 
greater than 432 in 2015, SDG-target ARRs exceed 7.5% to reduce the MMR to be below 
140 in 2030.
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Discussion
Our analysis provides a comprehensive analysis of global maternal mortality trends based on 
the latest data available from 171 countries. Globally, the MMR decreased by 43.9% (34.0 to 
48.7) from 1990 to 2015, with a global 2015 MMR estimate of 216 (207 to 249) deaths per 
100,000 live births, corresponding to a total of 303,000 (291,000 to 349,000) maternal 
deaths. Hence, the maternal mortality ratio has declined substantially between 1990 and 
2015 but progress has been much slower than required to meet the MDG 5 target of reducing 
the MMR by 75% between 1990 and 2015. The global summary masks variation in progress 
across regions and in particular, across countries. At the country level, among countries with 
an MMR greater than 100 in 1990, changes range from an increase of 34.0 (6.5 to 91.2) for 
Guyana to a decrease of 90.0% (78.9 to 94.6) for the Maldives.
Understanding the drivers of successful progress in reducing maternal mortality, as well as 
the factors impeding progress are key to informed decision making for reducing the MMR in 
the post-MDG era. Box 1 summarizes country case studies.
BOX 1
Country examples of accelerated decline of maternal mortality
Individual case studies have been carried out to analyse the drivers of MMR declines in 
various countries. In additional, collaborative initiatives such as Countdown to 2015, have 
published reports and country profiles for high burden countries to discuss coverage of 
care and its major determinants, including patterns of equity, policies, health system 
performance measures, and financial flows, at both the global and country levels to 
understand the underlying factors contributing to improvements in maternal (and 
newborn, child) health (21). Below, we highlight the achievements of three countries 
Bangladesh, Cambodia, and Rwanda.
In Bangladesh, a case study examined policy formulation and programme initiatives, 
availability and access to reproductive and maternal health services, and assessed changes 
in coverage of key reproductive health interventions. The study also examined relevant 
contextual factors such as education, access to information, and economic conditions (21, 
22). Broadly, the analyses using survey data from 2001 and 2010 found that factors both 
directly linked to health services and those distal such as improved transportation, access 
to mobile technology (and thus communication channels for information and social 
assistance), as well as education and socio-economic status influence maternal health (21, 
22). Notably, a near doubling in the proportion of girls with at least some secondary 
education is believed to be empowering, raising her potential for effective response to 
maternal complications as well as her ability to navigate the health care system (21, 22). 
The experience of Bangladesh notably demonstrates the need to look beyond the health 
care system when considering how to enact game-changing policies to reduce maternal 
mortality.
Between 1990 and 2015, both Cambodia and Rwanda had accelerated rates of reduction 
of maternal mortality. Cambodia reduced maternal mortality, with the ARR of 7.4% (5.6 
to 8.7), and Rwanda, with an ARR of 6.0% (4.5 to 7.4). In Cambodia, access to health 
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care was improved through heavy government investment in transport infrastructure and 
in health facilities, from local-level health posts and health centres to referral and national 
hospitals. Specifically in the area of reproductive, maternal and child health, innovative 
policies and programme responses have been among strategic priorities in Cambodia 
from the mid-2000s including a systematic programme to improve the utilization of 
maternal and newborn health services in public facilities whereby health centres started 
to operate 24 hours per day and maternity waiting houses and extended delivery rooms 
were added at health centers to make maternity services more accessible. The Cambodian 
Ministry of Health also adopted a strategy of increasing both the training of midwives 
and their absorption into the health system through targeted deployment. To further 
increase the proportion of births attended by a skilled midwife, financial incentives were 
offered to health workers. (23)
Rwanda’s substantial reductions in maternal mortality have been linked to a range of key 
policy and programme interventions. These include the strengthening of the health 
workforce and infrastructure by the Ministry of Health through the training and 
deploying of 45,000 community health workers (CHWs) nationwide, including at the 
village level. A national performance-based financing system incentivizes CHWs by 
rewarding them according to improvements on selected indicators, including the 
proportion of women delivering at health facilities. Rwanda also prioritized strong 
community involvement in the strengthening of the health workforce, allowing villages to 
elect the three individuals best suited to serve as their CHWs. Additionally, a 
comprehensive and community-based health insurance scheme has lowered financial 
thresholds for accessing maternal and child health services and thus expanded access to 
poorer populations. Finally, Rwanda has greatly strengthened its data collection system to 
improve priority-setting, planning, and resource allocation: all maternal and child health 
services have been integrated under one national monitoring and evaluation framework, a 
web-based Health Management Information System has been developed and deployed 
and maternal death reviews were scaled up. (24)
Together, these examples illustrate how expansion of service coverage and increasing the 
number of health care providers, setting standards of care, when referrals should be 
made, and training programmes for qualified health providers such as midwives helped to 
accelerate progress in reducing maternal mortality (21–25). These examples also 
demonstrate the need to balance quality of care and avoidance of over-medicalization in 
the quest to reduce maternal mortality. (25, 26)
While country success stories provide practical guidance and inspiration for targeted 
interventions to reduce maternal mortality, country-specific studies also help to better 
understand major risk factors and potential solutions in any country with high maternal 
mortality levels so that directed action can be taken. A study in Tanzania suggested that the 
distance to a health clinic and quality of care were factors contributing to high maternal 
mortality outcomes. (27) For countries with high HIV prevalence, indirect AIDS maternal 
deaths have contributed to higher maternal mortality in the last two decades (see web 
appendix table 5, pp 109–124). Reflecting the effect of interventions, with the increase in 
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anti-retroviral medication use, greater progress can be made in years to come in countries 
with generalized HIV/AIDS epidemics
Another potential factor that may hinder progress in reducing maternal mortality is an 
ongoing or emerging humanitarian crisis or fragile settings of conflict, post-conflict or 
disaster situations. (28) Further compounding this barrier, is that evidence and analyses of 
these events in these settings often remain anecdotal---collecting data on health outcomes in 
crisis situations is often not done. While comprehensive provision of maternal and child 
health interventions may be unrealistic to carry out in countries faced with conflict or natural 
disaster, targeted actions such as routine obstetric care during crises may still be possible and 
could reduce maternal mortality from preventable causes. (29)
In 2000 when the MDGs were endorsed, 98 countries had civil registration systems in place, 
37 countries had nationally representative surveys conducted in the prior 5–7 years, and few 
specialized reports on maternal mortality existed. To overcome the limitations of data 
availability, statistical models have been used to make assessments on progress in maternal 
health. For the assessment of levels and trends in maternal mortality, we developed a new 
estimation approach which extended and improved upon the methodology used in past UN 
MMEIG publications to capture data-driven trends in all countries, while accounting for 
systematic and random errors in the data inputs. (6–8, 16) Validation exercises suggest that 
the new model is reasonably well calibrated.(16) In addition to an update to the 
methodology used for estimating maternal mortality, we also updated the MMEIG data base 
with over 200 new entries such that the current estimates are based on 2,608 observations 
corresponding to 3634 country-years of information in 171 countries and used updated 
estimates for covariates and the number of live births. Figure 1 in the web appendix provides 
an overview of differences between UN MMEIG estimates published in 2014 and these 
revised estimates, and decomposes differences into those due to new methods versus 
updated inputs. (11)
Despite the advances in modelling procedure and data base used, challenges remain 
regarding the estimation of maternal mortality and there are important limitations to our 
study. Estimating maternal mortality is challenging because of limited maternal mortality 
data availability. For example, for 9 out of 171 countries with empirical evidence, there are 
no data points from 2005 or later, and for 55 out of 171 countries, there is no information 
since 2010. Moreover, the substantial uncertainty surrounding observations due to random 
errors (including sampling and/or stochastic errors), as well as uncertainty due to systematic 
errors in reporting need to be accounted for.
The misclassification of maternal deaths in vital registration systems remains a great 
obstacle to accurate measurement of maternal mortality in higher income countries. While 
the addition of a “pregnancy check box” on ICD coding documents has improved death 
classification for maternal deaths, they continue to be classified outside of related ICD-10 
codes. (8) Acknowledging these classification difficulties, countries such as Kazakhstan, 
Mexico, and Cuba have implemented specialized surveillance systems and administrative 
protocols to review and correct cause of death assignment before submission to vital 
statistical departments hence eliminating systematic misclassification errors. (30–32) If 
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implemented in more countries, this would result in more accurate reporting and provide the 
basis for additional analyses of misclassification that may inform misclassification 
adjustments for countries without such systems.
In addition to the classification issues in VR data, another reporting issue relates to the 
impact of the evolving definition and conceptualization of what is a maternal death. During 
the MDG reporting period, countries with VR systems in place transitioned from ICD-9 to 
ICD-10. Whereas deaths reported by ICD-9 codes cannot be explicitly identified by timing, 
ICD-10 introduced the concept of “late maternal deaths”; those that occur after 42 days but 
up to 1 year after the end of a pregnancy. Since the introduction of these late maternal death 
codes (O96 and O97), a rise in number late maternal deaths as well as increasing cases of 
near-miss cases and maternal morbidity has been observed and described by the “obstetric 
transition” phenomenon (33). While improvements in health care likely contribute to this 
phenomenon, the potential contribution of changes in reporting also warrants further 
investigation. Measurement considerations are especially relevant for the release of the 11th 
revision of the ICD, which is anticipated in 2018, and will be implemented in countries 
through the latter half of the SDG monitoring period.
For countries without well-functioning VR systems, well-designed research studies and 
surveillance systems can collect data to undertake cause-specific analyses of mortality to 
assess the proportion of deaths that are due to maternal causes. (35) However, many 
countries rely on the reporting of pregnancy-related mortality for estimating maternal 
mortality, which is challenging because of limited availability of data which allow for a 
detailed analysis of how pregnancy-related mortality compares to maternal mortality at the 
national level, and by the additional challenge of defining and estimating which proportion 
of pregnancy-related AIDS deaths should be counted as maternal deaths due to the 
aggravating effect of the pregnancy. (8, 35) Recent subnational studies, such as the one 
carried out by the INDEPTH surveillance network may also provide new insights for 
estimates. (35) The extent of under- or over-reporting of proportion of pregnancy-related 
deaths is another uncertain factor. While past studies suggested the underreporting of 
pregnancy-related PMs (11), a recent study in a demographic surveillance site in Senegal 
found that the proportion of pregnancy-related deaths was over-reported when using a DHS 
questionnaire, and that a siblings’ survival calendar may provide a better instrument for 
measuring pregnancy-related mortality. (36) Further studies are needed to test the validity of 
these findings in other settings. More generally, to improve maternal mortality estimates, 
future endeavours related to maternal health monitoring should take into account how data 
are collected and determine mechanisms to “standardize” data in order to minimize 
reporting biases (9).
In addition to the limitations due to maternal mortality data issues, the dependency of the 
maternal mortality estimation on the estimation of adult female mortality as well as the 
number of births, implies that the challenges and limitations that apply to the estimation of 
these two indicators are also applicable to maternal mortality estimation. (12, 13) Longer 
term, uncertainty assessments should include the uncertainty in related indicators such as 
covariates, all-cause deaths and births. A further limitation is the need to rely on predictor 
covariates whenever empiric country observations are lacking. Compounding this limitation 
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is the challenge in constructing time series of covariates that are comparable across countries 
and within countries over time. Doing so for one of the predictor covariates used, skilled 
birth attendance, is particularly challenging due to issues with definition as well as reporting. 
(37–40) Given the great uncertainty in maternal mortality indicators, more attention need to 
be given to the presentation and interpretation of uncertainty intervals. In addition, users of 
MMR estimates should be warned against post-hoc analyses for countries with limited data, 
such as correlating the MMR estimates with coverage indicators, given the great uncertainty 
surrounding the MMR estimates and the covariate-driven estimation approach.
Differences exist between the UN MMEIG MMR estimates and those produced by the 
Global Burden of Disease study 2013. (41) Table 6 in the web appendix provides an 
overview of differences in global and regional maternal deaths in 1990 and 2013 and figure 
3 in the web appendix shows a comparison of country estimates. Globally, the GBD 2013 
study estimated that there were 374,000 number of deaths in 1990, which is much lower 
than the 532,000 (496,000 to 590,000) maternal deaths estimated by the UN MMEIG. Large 
differences are observed in Southern Asia and Sub-Saharan Africa. For 2013, differences are 
smaller: the GBD study estimates 292,000 deaths compared to 315,000 (303,000 to 356,000) 
deaths estimated in this study. Differences in estimates may be due to differences in 
estimates of all-cause deaths: all-cause mortality estimates are much lower in the GBD 
study, as compared to all-cause mortality used by UN MMEIG for the great majority of 
countries in sub-Saharan Africa in 1990, and GBD all-cause mortality estimates may be 
subject to underestimation for those countries where estimation relies largely on DHS 
sibling histories. (42) Other explanations for differences in estimates include differences in 
the preprocessing of input data (i.e. VR and DHS data), differences in the estimates of the 
number of births (GBD 2013 used births from the World Population Prospects 2012 revision 
while the UN MMEIG used birth estimates from the World Population Prospects 2015) as 
well as differences in the models and covariates used for estimating maternal mortality 
outcomes. More analysis is necessary to better understand the contribution of the various 
differences in modeling to the differences in estimates at the country and regional level.
While transitioning from MDG 5 monitoring to the discussion of maternal mortality related 
targets for the SDGs, a vision of ending all preventable maternal deaths has emerged. (43) 
While it is recognized that even in the best of circumstances, maternal deaths may still 
occur, in a world without preventable maternal deaths, everything that could be done to 
avoid a maternal death is done and is done appropriately. Working towards this aim, the 
SDG target of reducing global maternal mortality to less than 70 deaths per 100,000 live 
births by 2030 has been proposed as part of the SDG outcome document. (9, 10) Our 
projections suggest that the achievement of the SDG maternal mortality target would result 
in 60.1% fewer maternal deaths in the year 2030, and 1.4 million fewer deaths cumulatively 
from 2016 to 2030, as compared to a projection to 2030 based on an ARR of 2.9%, as 
estimated for a typical country during 2000–2010. The ARR required to achieve the SDGs 
(7.5%) is higher than the ARR which would have led to achievement of the MDGs (5.5%).
While the pay-off of achieving the SDG target is clear based on the projected reduction in 
number of maternal deaths, much work is needed at the country-level to accomplish this 
ambitious goal in the coming 15 years. Continued research on what efforts and innovations 
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have the greatest impact to maternal mortality reductions will aid resource allocation and 
priority setting. The required acceleration will not be possible without a combination of 
interventions and actions taken, along the lines of the concerted efforts taken by countries 
that succeeded in bringing about a substantial maternal mortality decline in a short period of 
time. While each country context will be different, the Ending Preventable Maternal 
Mortality Strategy suggests for adaptive, highly effective interventions to improve women’s 
health, before, during, and after pregnancy. (9) Future discussion on interventions must be 
informed by the content and quality of the care provided; efforts to define and delineate what 
constitutes “high quality” care, which would be expected to decrease mortality and 
morbidity, are underway (44). These strategies are complemented by analyses such as LiST 
and the One Health Tool, which provide insight on the cost-effectiveness and impact on 
mortality reduction. (45, 46) Achievement of the target will also require the strengthening of 
robust information systems to monitor progress and inform priority-setting, planning, and 
resource allocation. The importance of high quality data, specifically on cause of death, to 
inform decision making and to ultimately reduce maternal mortality is highlighted in the UN 
Global Strategy for Women’s, Children’s and Adolescents Health-thus putting data 
collection at the center of political attention. (47, 48)
While the activities and resources needed to accomplish the SDG target may seem 
overwhelmingly ambitious, current evidence suggests that ten countries-including Cambodia 
and Rwanda-experienced rates of reduction that exceeded those necessary for the required 
SDG target. Moreover, a world where millions of preventable maternal deaths continue to 
occur on an annual basis is not acceptable as an alternative scenario. Hence, the time for 
action is now.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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PANEL: Research in context
Evidence before this study
All publicly available data on maternal mortality are compiled on a regular basis by the 
United Nations Maternal Mortality Inter-agency Group (UN MMEIG) to improve 
monitoring of progress towards maternal survival goals, and to enhance the capacity of 
countries to produce timely estimates of maternal mortality. (6–8) Prior to this study, the 
global database contained 2374 records and UN MMEIG estimates of maternal mortality 
levels and trends were constructed using that data base and a multilevel regression model 
for countries without sufficient high-quality information from vital registration systems. 
(8)
Added value of this study
This study extended the existing UN MMEIG global database by including 234 
additional records. We developed a modelling approach that extends and improves upon 
the methodology used in prior studies, to construct estimates for 183 countries that 
capture data-driven trends in all countries, while accounting for systematic and random 
errors in the observations. (16)
For the first time, this study publishes country-specific MMR estimates up to the MDG 
target year (2015) and assesses achievements in reducing the MMR between 1990 and 
2015. Globally, we estimated that the MMR declined from 385 deaths per 100,000 live 
births (80% uncertainty interval ranges from 359 to 427) in 1990 to 216 (207 to 249) in 
2015. Scenario-based projections from 2016 to 2030 provide insights into the future 
burden of maternal deaths: in the next 15 years, 3.9 million women would die from a 
maternal cause of death if each country would continue to reduce its MMR at an annual 
rate of reduction of 2.9%, which is the median outcome of country-specific rates of 
reductions estimated from 2000 to 2010. Under the SDG target, the total number of 
projected cumulative deaths between 2016 and 2030 is 2.5 million, hence 1.4 million 
lower than the scenario based on a continuation of recent rates of change.
Implications of all the available evidence
With the vision of ending preventable maternal deaths and the mission to reduce the 
global MMR to 70 deaths per 100,000 in the next 15 years, urgent action is needed to 
accelerate progress, in particular in countries with substantial maternal mortality burdens. 
Future action may be guided by past successes in countries with successful concerted 
efforts to reduce the MMR. Future research on what efforts contribute most effectively to 
maternal mortality reductions will aid resource allocation and priority setting.
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Figure 1. Global and regional MMR estimates (per 100,000 live births) from 1990 to 2015
Shaded areas refer to 80% UIs. Note: y-axes differ; grey shaded areas in background are 
comparable across graphs.
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Figure 2. Maternal mortality ratio (per 100,000 live births) for 2015 by country
A: point estimates, B: lower bounds of 80% UIs, C: upper bounds of 80% UIs
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Figure 3. Relative reduction from 1990 to 2015 for 95 countries with MMR >100 in 1990
Countries are grouped based on the categories from Table 6, where LB refers to lower bound 
of the 80% UI. Within each category, countries are sorted by the point estimate of the 
relative reduction. Horizontal lines refer to 80% UIs, such that there is a 1 in 10 chance that 
the relative reduction is greater than the reported upper bound and there is a 1 in 10 chance 
that the relative reductions is smaller than the reported lower bound. Abbreviations of 
country names: DRC = Democratic Republic of the Congo, OPT = Occupied Palestinian 
Territory.
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Figure 4. 
Life time risk (*1,000) of a maternal death 1990 and 2015, globally and by region.
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Table 1
Definitions related to maternal and pregnancy-related mortality.
Maternal death Death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the 
duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its 
management but not from accidental or incidental causes.
Pregnancy-related death Death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the cause 
of death.
Late maternal death Death of a woman from direct or indirect obstetric causes, more than 42 days, but less than one year after 
termination of pregnancy.
PM Proportion of maternal deaths among deaths of women of reproductive age.
Pregnancy-related PM Proportion of pregnancy-related deaths among deaths of women of reproductive age.
Maternal mortality ratio (MMR) Number of maternal deaths per 100,000 live births.
Maternal mortality rate The ratio of maternal deaths to the women-years of exposure for the age group 15–49.
Life time risk The probability of a 15-year-old woman eventually dying from a maternal cause, assuming she is subjected 
throughout her lifetime to the risks of maternal death as estimated for that country-year. (17)
Annual (continuous) rate of 
reduction (ARR)
Measure of relative decline per year, defined as
ARR = log(MMRt2/MMRt1)/(t1−t2) where t1 and t2 refer to different years with t1 < t2.
Lancet. Author manuscript; available in PMC 2017 July 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Alkema et al. Page 25
Table 2
Overview of data sources, the collection method, and reporting characteristics.
Data source type Method of collection Type of death 
reported
Time frame of death 
reported after pregnancy 
termination
Civil registration vital statistics 
(VR)
Death certificate data. certifier provides cause 
of death information which is coded into ICD.
Maternal 1 ICD-9 coding: 
up to one year
2 ICD-10 coding: 
up 42 days as 
well as between 
42 days and 1 
year
Specialized studies:
Confidential Inquires, 
Reproductive-age mortality 
studies (RAMOS), Specialized 
Studies (e.g. using verbal 
autopsy, comparing maternal 
mortality surveillance systems 
with civil registration data)
Review of causes and/or specific review for 
underreporting (combination of 
misclassification and incompleteness)
Maternal deaths Depends on review parameters
Population-based surveys that 
collect sibling histories 
including:
DHS; MICS4, Reproductive 
Health Survey, Maternal 
Mortality Survey, Family 
Health Survey
Direct “sisterhood” method: A representative 
sample of women are asked about the survival 
of all their sisters, to determine:
• the age;
• how many are alive;
• how many are dead;
• for those who died: age at death 
and whether the sister died 
during pregnancy, delivery or 
within two months of pregnancy.
Pregnancy- related Two months
Census , post-census 
enumeration survey
Population censuses can include questions on 
deaths in households in defined recent reference 
period. Reported deaths of reproductive aged 
women trigger questions about the timing of 
death relative to pregnancy.
Pregnancy- related Up to 1 year
Other sources reporting on 
maternal mortality:
Maternal mortality surveillance 
system, Ministry of Health, 
National Statistical Offices
Review of causes. Maternal and/or 
pregnancy- related
Depends on review parameters
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Table 3
Overview of data sources that are included in the maternal mortality model and the systematic and random 
errors associated with the observations for each source type that are taken into account in the data model.
Data source type Information used to 
construct maternal 
mortality estimates
Assumptions about systematic errors 
(reporting issues which result in biases)
Assumptions about 
random errors
 A1. Civil registration vital 
statistics, ICD 9 (VR-ICD9)
PM (including late maternal 
deaths)
1 Misclassification of maternal 
deaths and/or incompleteness
2 Inclusion of late maternal 
deaths
Observations are 
subject to stochastic 
errors
 A2. Civil registration vital 
statistics, ICD 10 (VR-ICD10) PM
Misclassification of maternal deaths and/or 
incompleteness
 B. Specialized studies
Maternal deaths are used a 
model input if a rigorous 
assessment of the total 
number of all- cause deaths 
was also carried out in the 
study to confirm that all 
deaths to women of 
reproductive age were 
captured. Otherwise, the PM 
or MMR is used*.
No systematic errors
 C. Other data sources reporting 
on maternal mortality PM or MMR
* Underreporting of maternal deaths
Observations may be 
subject to sampling, 
stochastic and/or 
additional random error
 D. Other data sources reporting 
on pregnancy-related mortality, 
e.g. through sibling histories
Pregnancy-related PM or 
pregnancy- related MMR*
1 Underreporting of pregnancy-
related deaths
2 Over-reporting of maternal 
deaths due to the inclusion of 
pregnancy-related deaths that 
are not maternal
*
PM takes precedence over the MMR.
Additional definitions used: Stochastic errors refer to differences between observed PMs and expected PMs due to the randomness associated with 
the event of a maternal death, i.e., when considering the event of a maternal death as the outcome of a random variable with a Bernouilli 
distribution with the probability of a maternal death given by the expected PM. Sampling error arises in observed PMs that are obtained from 
samples that are a subset of the population, e.g. in surveys or sample registration systems. In addition to sampling or stochastic errors, observations 
may be due to additional random errors, which are non-systematic errors that may occur at any point during the data collection process, e.g. due to 
how a questionnaire was administered or due to data entry errors. Abbreviations: PM = proportion of all-cause deaths that are maternal; MMR = 
maternal mortality ratio; VR = vital registration.
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Table 4
Overview of data inputs used in the maternal mortality model.
Source type # records # country-years
A. VR 2025 years of reporting 2025
B. Specialized studies 224 studies 364
C. Other sources - reporting on maternal mortality 178 reports/studies 206
D. Other sources - reporting on pregnancy-related mortality 181 reports/studies 1038
All 2608 records 3634
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Table 5
Categorization of countries based on evidence for progress in reducing the MMR between 
1990 and 2015
Categories are defined based on two probability statements regarding minimum relative reductions in the 
MMR between 1990 and 2015, where the first statement is true with at least 50% chance while the second 
statement is true with at least a 90% chance. The two columns on the right provide the corresponding criteria 
based on point estimates and lower bound of 80% UIs for the probability statements in each of the categories 
to hold true. Note that lower bounds of 80% UIs provide one-sided probability statements that refer to 10% or 
90% chance.
Category
Definition based on probabilities regarding relative reductions 
between 1990 and 2015
Per cent reduction in MMR from 1990 to 2015
Point estimate for % 
reduction
Lower bound of 80% UI
1 Probability(reduction is at least 75%) > 50% > 75% Not applicable
2 Probability(reduction is at least 50%) > 50% AND
Probability(reduction is at least 25%) > 90% > 50% > 25%
3 Probability(reduction is at least 25%) > 50% AND
Probability(reduction is at least 0%) > 90% > 25% > 0%
4 Probability(reduction is at least 25%) < 50% OR
Probability(reduction is at least 0%) < 90%
Point estimate < 25% and/or lower bound < 0%
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